Surjit Bhimarao Dixit
Keine laufenden Positionen mehr
Karriereverlauf von Surjit Bhimarao Dixit
Ehemalige bekannte Positionen von Surjit Bhimarao Dixit
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Wesleyan University | Corporate Officer/Principal | 01.01.2005 | 01.07.2007 |
| Henri Poincaré University | Corporate Officer/Principal | 01.10.1999 | 01.02.2001 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2007 | - |
Ausbildung von Surjit Bhimarao Dixit
| Indian Institute of Technology New Delhi | Doctorate Degree |
Statistik
International
| Kanada | 2 |
| Vereinigte Staaten | 2 |
| Indien | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Surjit Bhimarao Dixit
- Erfahrung